申请人:Otsuka Pharmaceutical Company, Limited
公开号:US04874764A1
公开(公告)日:1989-10-17
Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.3 is C.sub.1 -C.sub.6 alkyl and R.sup.F is C.sub.1 -C.sub.6 alkyl, and a pharmaceutically acceptable salts thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.
具有优异抗微生物活性的化合物为4-氧喹啉-3-羧酸类化合物,其化学式为:##STR1## 其中R.sup.3为C.sub.1 -C.sub.6烷基,R.sup.F为C.sub.1 -C.sub.6烷基,以及其药学上可接受的盐。这些化合物可用作抗微生物剂,并且包含该化合物作为活性成分的药物组合物。